Laxmi Dental is all set to acquire shares in its foreign material subsidiary -- Laxmi Dental Lab USA Inc., up to an amount of $1 million in pursuance to an Investment Agreement with Laxmi Dental Lab USA Inc. dated December 24, 2024, to formalize the terms of the strategic investment. The company has obtained the necessary approval from the Reserve Bank of India (RBI), for transferring the said amount and the amount has been transferred on April 16, 2025.
As a result of the strategic investment, the company’s ownership in Laxmi Dental Lab USA, Inc. will increase from 55.56% to 71.43%, following the issuance of additional equity shares, which will raise the total number of shares from 10,000 to 20,000.
Laxmi Dental and its subsidiaries (the Group), are manufacturer of dental products, with many years history of innovation and service to the dental industry and patients.
| Company Name | CMP |
|---|---|
| Lenskart Solutions | 539.80 |
| Poly Medicure | 1497.15 |
| Laxmi Denta | 198.55 |
| Nureca Ltd. | 262.50 |
| Hemant Surgical Inds | 296.85 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: